Stryker Corporation (SYK) stock prices updated...

Stryker Corporation stock price

Stryker Corporation latest news:

  • 11/09/2017 07:03:50

    BRIEF-Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms

    Stryker Corp(SYK). * Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms. * Stryker Corp (SYK) - ‍Approval allows company to begin U.S. commercialization efforts for Neuroform Atlas stent system​ immediately Source text for Eikon: Further company coverage:

  • 08/23/2017 14:43:40

    Lowe's and Stryker fall while Express and Wal-Mart rise

    Lowe's and Stryker slide while Express and Wal-Mart Stores advance

  • 08/23/2017 09:44:05

    Stryker Corp. stock drops 4% on voluntary recall, temporary ship hold and lowered 2017 earnings guidance

    Stryker Corp. said early Wednesday that it has issued a voluntary recall for specific lots of Oral Care products and that it placed a temporary ship hold on cloth-based products, which make up about half of Stryker's Sage Products' revenue, until they are tested. The Food and Drug Administration previously warned the company about these two issues in a July letter. The company now expects full year adjusted earnings to be at the lower end of its previously stated range of $6.45 to $6.55 and third quarter adjusted earnings to be at the lower end of a previously stated $1.50 to $1.55 range. The stock dropped 4.2% in extremely heavy midday trade Wednesday. The voluntary recall involves certain lots of Oral Care products sold through Stryker's Sage Products business unit that were manufactured by a third-party supplier and distributed between July 2015 and August 2017. Stryker said there was a possibility of cross-contamination due to equipment that manufactured Oral Care products being shared with non-pharmaceutical products. Stryker said there have been some reports of minor irritation and allergic reaction but that the company has not been told of any serious safety issues. The company has stopped doing business with the third-party supplier, is now manufacturing Oral Care products in house and expects to continue shipping the products in September. Stryker is also placing a temporary ship hold on cloth-based products and expects to begin shipping again in September. The FDA said in its July letter that it had concerns about microbiological testing methods for all products containing solutions sold by Sage, including the recalled Oral Care products and solutions in cloth-based products; the regulator said they should be tested using a different method that takes a longer time to do, which accounts for Stryker's temporary ship hold. Stryker shares have surged 16.4% year-to-date to $139.40, compared with a 9.4% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit for more information on this news.

  • More trends:

    SturmRGR | Suburban Propane PartnersSPH | Sumitomo Mitsui Financial Group IncSMFG | Summit Hotel PropertiesINN | Summit Hotel PropertiesINN^A | Summit Hotel PropertiesINN^B | Summit Hotel PropertiesINN^C | Summit MaterialsSUM | Summit Midstream PartnersSMLP | Sun CommunitiesSUI |